Bicycle Therapeutics plc (50BA) — Working Capital to Net Assets Ratio
Bicycle Therapeutics plc (50BA) has a Working Capital to Net Assets ratio of 102.9% as of March 2026. Working capital of €570.25 Million (current assets of €619.13 Million minus current liabilities of €48.89 Million) is measured against net assets of €554.32 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 50BA net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bicycle Therapeutics plc Working Capital to Net Assets (2018–2025)
This chart shows how Bicycle Therapeutics plc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 102.9%, reflecting working capital of €570.25 Million against net assets of €554.32 Million EUR. Check 50BA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Bicycle Therapeutics plc (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bicycle Therapeutics plc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Bicycle Therapeutics plc.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 102.6% | €625.90 Million | €609.98 Million | €682.88 Million | €56.98 Million | ▼ -6.0 pp |
| 2024 | 108.6% | €861.38 Million | €793.06 Million | €928.61 Million | €67.23 Million | ▼ -24.1 pp |
| 2023 | 132.7% | €492.33 Million | €370.93 Million | €561.87 Million | €69.54 Million | ▲ +16.0 pp |
| 2022 | 116.7% | €316.04 Million | €270.78 Million | €369.38 Million | €53.34 Million | ▼ -5.3 pp |
| 2021 | 122.0% | €422.32 Million | €346.25 Million | €458.56 Million | €36.24 Million | ▼ -16.9 pp |
| 2020 | 138.9% | €132.59 Million | €95.46 Million | €155.72 Million | €23.13 Million | ▲ +36.6 pp |
| 2019 | 102.3% | €95.33 Million | €93.20 Million | €104.15 Million | €8.82 Million | ▲ +199.4 pp |
| 2018 | -97.2% | €67.84 Million | €-69.83 Million | €76.77 Million | €8.93 Million | — |